Pancreatic Cancer Research

ResearcherAmsterdam University Medical CentersActive in the last 2 years

Aart Johannes Nederveen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5477-973X; OpenAlex author ID A5070504139. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: none · 2018: 3 papers · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: 1 paper

Papers 10

  1. MR Elastography of the Pancreas: Bowel Preparation and Repeatability Assessment in Pancreatic Cancer Patients and Healthy Controls. Co-author DOI 10.1002/jmri.28918↗
  2. Added value of 3T MRI and the MRI-halo sign in assessing resectability of locally advanced pancreatic cancer following induction chemotherapy (IMAGE-MRI): pros… Co-author DOI 10.1007/s00423-022-02653-y↗
  3. Deep learning DCE-MRI parameter estimation: Application in pancreatic cancer. Co-author DOI 10.1016/j.media.2022.102512↗
  4. Improved unsupervised physics-informed deep learning for intravoxel incoherent motion modeling and evaluation in pancreatic cancer patients. Co-author DOI 10.1002/mrm.28852↗
  5. Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer. Co-author DOI 10.3390/cancers13194869↗
  6. Evaluation of Six Diffusion-weighted MRI Models for Assessing Effects of Neoadjuvant Chemoradiation in Pancreatic Cancer Patients. Last author DOI 10.1016/j.ijrobp.2018.04.064↗
  7. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.mri.2018.02.005↗
  8. Comparison of six fit algorithms for the intra-voxel incoherent motion model of diffusion-weighted magnetic resonance imaging data of pancreatic cancer patient… Last author DOI 10.1371/journal.pone.0194590↗
  9. Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer. Co-author DOI 10.1016/j.radonc.2015.05.009↗
  10. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI. Co-author DOI 10.1118/1.4918753↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hanneke W.M. van Laarhoven · 9 shared papers, 2015–2024 · strength 1.03
  2. Remy Klaassen · 9 shared papers, 2015–2022 · strength 0.88
  3. Oliver J. Gurney‐Champion · 8 shared papers, 2015–2022 · strength 0.83
  4. Johanna W. Wilmink · 7 shared papers, 2015–2024 · strength 0.73
  5. Marc G. Besselink · 6 shared papers, 2015–2024 · strength 0.61
  6. Nienke Petronella Maria Wassenaar · 2 shared papers, 2021–2024 · strength 0.33
  7. Johannes Crezee · 2 shared papers, 2021–2022 · strength 0.30
  8. Arjan Bel · 3 shared papers, 2015–2018 · strength 0.20
  9. Jurgen Henk Runge · 1 shared paper, 2024 · strength 0.20
  10. Geertjan van Tienhoven · 3 shared papers, 2015–2018 · strength 0.17
  11. Tim Ottens · 1 shared paper, 2022 · strength 0.16
  12. Misha Kaandorp · 1 shared paper, 2021 · strength 0.14
  13. Dick J. Richel · 1 shared paper, 2021 · strength 0.12
  14. Esther N. Pijnappel · 1 shared paper, 2021 · strength 0.12
  15. L. Bengt van Rijssen · 1 shared paper, 2022 · strength 0.12
  16. Krijn P. van Lienden · 1 shared paper, 2022 · strength 0.12
  17. Leonard W. F. Seelen · 1 shared paper, 2022 · strength 0.12
  18. Eran van Veldhuisen · 1 shared paper, 2022 · strength 0.12
  19. Thomas F. Stoop · 1 shared paper, 2022 · strength 0.12
  20. Ignace H. J. T. de Hingh · 1 shared paper, 2022 · strength 0.12
  21. Hendrik A. Marsman · 1 shared paper, 2022 · strength 0.12
  22. Antonetta C. Houweling · 1 shared paper, 2015 · strength 0.05
  23. E. Lens · 1 shared paper, 2015 · strength 0.05
  24. Jeanin Elise van Hooft · 1 shared paper, 2015 · strength 0.05
  25. Astrid van der Horst · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.